Modular fully-connected convolutional neural network: a new method for searching biological active compounds

Cover Page

Cite item

Full Text

Abstract

Relevance: Machine learning methods are widely used today in the search for pharmacological compounds. The nature and internal structure of chemical and biological data are highly specific, and the vast majority of drugs act simultaneously on multiple biotargets. Given this, the development of new artificial neural network architectures for analyzing the relationships between the biological activity and structure of chemical compounds, taking into account the specific nature of chemical and biological information and the interactions of compounds with multiple biotargets, is important and scientifically relevant task.

Objective: To create a new architecture for a modular multi-target fully connected convolutional neural network based on correlation convolution of energy spectra of multiple docking to multiple biotargets, for the in silico searching biological active compounds.

Materials and methods: Ensemble multiple docking of 234 compounds with antimicrobial activity against S. aureus and 537 compounds with anxiolytic activity into 10 and 22 relevant biotargets, respectively, and the generation of their energy spectra of multiple docking were performed using the original MSite program and AutoDock Vina program. Using the obtained energy spectra of multiple docking, two modular multi-target fully-connected convolutional correlation neural networks were constructed using the original FCCorNet program. These networks describe the dependences of the levels of antibacterial activity against S. aureus and anxiolytic activity of chemical compounds on the energies of their modular neural networks. The accuracy and statistical significance of the constructed neural network models were assessed using correlation analysis, one-way analysis of variance, and threshold classification.

Results and discussion: The accuracy of the constructed neural network model for the antimicrobial S. aureus activity was Acc = 78.9 %, with statistical significance p = 3.44 × 10-12. The accuracy of the constructed neural network model for anxiolytic activity was Acc = 61.3 %, with statistical significance p = 6.68 × 10-8. The accuracy of predicting the antimicrobial S. aureus activity exceeds the accuracy of predicting the anxiolytic activity, which is probably due to a more complex systemic multi-target mechanism for implementing psychotropic effects, in comparison with the antibacterial action of chemical compounds. The obtained results prove the high validity of using the new architecture of the modular multi-target fully connected convolutional correlation neural network based on the energy spectra of multiple docking for in silico searching biological active substances.

Conclusion: A new artificial intelligence method for in silico searching biological active compounds has been developed: a modular multi-target fully connected convolutional correlation neural network based on the energy spectra of multiple docking into relevant biotargets. Multivariate statistics methods demonstrated high accuracy and statistical significance of the constructed neural network models, reaching p = 3.44 × 10-12 for antibacterial activity against S. aureus and p = 6.68 × 10-8 for anxiolytic activity. The developed methodology can be used for in silico searching new highly active compounds with various types of systemic multi-target biological and pharmacological activity, taking into account their integrated affinity for relevant target proteins.

About the authors

Pavel M. Vasiliev

Volgograd State Medical University

Author for correspondence.
Email: pvassiliev@mail.ru
ORCID iD: 0000-0002-8188-5052

Doctor of Biological Sciences, Senior Researcher at the Higher Attestation Commission (Associate Professor), Head of the Laboratory of Information Technologies in Pharmacology and Computer Modeling of Medicines, Scientific Center for Innovative Medicines with Pilot Production, Professor of the Department of Pharmacology and Bioinformatics

Russian Federation, Volgograd

Arina V. Golubeva

Volgograd State Medical University

Email: arina_arina_golubeva@mail.ru
ORCID iD: 0000-0001-8268-8811

junior researcher at the Laboratory of Information Technologies in Pharmacology and Computer Modeling of Medicines, Scientific Center for Innovative Medicines with Pilot Production, Assistant Professor at the Department of Pharmacology and Bioinformatics

Russian Federation, Volgograd

Maxim A. Perfiliev

Volgograd State Medical University

Email: maxim.firu@yandex.com
ORCID iD: 0000-0002-5326-3299

Candidate of Medical Sciences, Junior Researcher at the Laboratory of Information Technologies in Pharmacology and Computer Modeling of Drugs, Research Center for Innovative Medicines with Pilot Production, Assistant Professor at the Department of Pharmacology and Bioinformatics

Russian Federation, Volgograd

Andrey N. Kochetkov

Volgograd State Medical University

Email: akocha@mail.ru
ORCID iD: 0000-0003-3077-1837

System Administrator, Software Engineer at the Laboratory of Information Technologies in Pharmacology and Computer Modeling of Medicines, Scientific Center for Innovative Medicines with Pilot Production

Russian Federation, Volgograd

References

  1. Sarkar C., Das B., Rawat V.S., Wahlang J.B., Nongpiur A., Tiewsoh I. et al. Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development. International Journal Molecular Sciences. 2023;24(3):2026.
  2. International standard ISO/IEC 22989:2022(E) Information technology ‒ Artificial intelligence ‒ Artificial intelligence concepts and terminology. Geneva (Switzerland): ISO/IEC, 2022. 15 p.
  3. Leijnen S., Van Veen F. The Neural Network Zoo. Proceedings. 2020;47(4):9.
  4. Scabini L.F.S., Bruno O.M. Structure and performance of fully connected neural networks: Emerging complex network properties. Physica A: Statistical Mechanics and its Applications. 2023;615:128585.
  5. Chen C., Isa N.A.M., Liu X. A review of convolutional neural network based methods for medical image classification. Computers in Biology and Medicine. 2025;185:109507.
  6. Aguiar C., Camps I. Molecular Docking in Drug Discovery: Techniques, Applications, and Advancements. Current Medicinal Chemistry. 2025;32(28):5924-5938.
  7. Bi X., Wang Y., Wang J., Liu C. Machine Learning for Multi-Target Drug Discovery: Challenges and Opportunities in Systems Pharmacology. Pharmaceutics. 2025;17:1186.
  8. Васильев П.М., Кочетков А.Н., Перфильев М.А. Нейросетевое моделирование зависимости гамкa-агонистической активности химических соединений от спектра энергий множественного докинга. Вестник Волгоградского государственного медицинского университета. 2022:19(4):88–93. doi: 10.19163/1994-9480-2022-19-4-88-93.
  9. Vassiliev P.M., Perfilev M.A., Golubeva A.V., Kochetkov A.N., Maltsev D.V. Multi-target neural network model of anxiolytic activity of chemical compounds using correlation convolution of multiple docking energy spectra. Biomeditsinskaya Khimiya. 2024;70(6):428–434. doi: 10.18097/PBMC20247006428.
  10. Trott O., Olson A.J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. Journal of Computational Chemistry. 2010;31(2):455–461.
  11. Hilbe J.M. Statistica 7: an overview. The American Statistician. 2007;61(1):91–94.
  12. Filimonov D.A., Lagunin A.A., Gloriozova T.A., Rudik A.V., Druzhilovskii D.S., Pogodin P.V., Poroikov V.V. Prediction of the biological activity spectra of organic compounds using the PASS online web resource. Chemistry of Heterocyclic Compounds. 2014;50(3):444–457.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2025 Vasiliev P.M., Golubeva A.V., Perfiliev M.A., Kochetkov A.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).